epigallocatechin gallate has been researched along with Dyslipidemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, B; Guan, S; Huang, Y; Jin, Y; Lu, J; Sun, B; Tao, S | 1 |
| An, Y; Chang, Y; Cheng, J; Dang, H; Feng, J; Guo, H; Luo, K; Ma, C; Qiao, L; Shao, H; Tian, J; Xie, L; Xing, W; Yang, J; Yuan, Y | 1 |
| Miltonprabu, S; Thangapandiyan, S | 1 |
3 other study(ies) available for epigallocatechin gallate and Dyslipidemia
| Article | Year |
|---|---|
Epigallocatechin-3-gallate protects against 1,3-dichloro-2-propanol-induced lipid accumulation in C57BL/6J mice.
Topics: alpha-Chlorohydrin; Animals; Antioxidants; Catechin; Dyslipidemias; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mutagens; Protective Agents | 2018 |
Caffeine-free hawk tea lowers cholesterol by reducing free cholesterol uptake and the production of very-low-density lipoprotein.
Topics: Animals; Anticholesteremic Agents; Biological Transport, Active; Caffeine; Catechin; Cholesterol; Disease Models, Animal; Dyslipidemias; Feeder Cells; Gastrointestinal Microbiome; Hep G2 Cells; Humans; Kaempferols; Lipid Metabolism; Lipoproteins, VLDL; Litsea; Liver; Male; Models, Biological; Quercetin; Rats; Rats, Sprague-Dawley; Receptors, LDL; Sterol Regulatory Element Binding Protein 2; Teas, Medicinal | 2019 |
Epigallocatechin gallate potentially attenuates Fluoride induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats.
Topics: Adenosine Triphosphatases; Animals; Antioxidants; Biomarkers; Body Weight; Calcium; Cardiotoxicity; Catechin; DNA Fragmentation; Drinking Behavior; Dyslipidemias; Feeding Behavior; Fluorides; Lipid Peroxidation; Lipids; Male; Membranes; Mitochondria, Heart; Myocardium; Organ Size; Oxidative Stress; Rats; Rats, Wistar | 2015 |